Using Medicare FFS claims data and county-level vaccination rates, we estimate savings of about $2.6 billion from reduced Medicare hospitalizations associated with COVID-19 vaccinations in early 2021.
Data
ASPE uses and produces data as key components of its work. ASPE studies and assesses data and how it is captured, managed, analyzed and protected, including the interplay of the sources, systems, standards for data that support policy, practice and research.
ASPE also co-chairs the HHS Data Council, which is the principal internal advisory body to the Secretary on health and human services data policy. The Council coordinates data policy activities in HHS, including the development and implementation of an HHS data strategy, and conducts research to improve long-term collection and use of HHS data.
ASPE’s work involves many types of data produced by HHS and other governmental programs and other partners. For example:
- Through its Foundations for Evidence-Based Policies Act of 2018 (“Evidence Act”) and Data Council responsibilities, ASPE leads HHS efforts to improve the quality and accessibility of its data assets.
- Through its investments under the aegis of the Office of the Secretary Patient-Centered Outcomes Research Trust Fund (OS-PCORTF), ASPE supports interoperability through such products as linked datasets involving mortality data, HL7 implementation guides in support of FHIR for research use of electronic health records, claims and other data, and natural language processing approaches.
- Through the use of ASPE-developed supplemental data tables, ASPE has developed issue brief series examining options before and after the passage of the American Rescue Plan Act of 2021 (ARP).
- Through its issue briefs such as this brief on Medicare Telehealth utilization trends, ASPE provides unique and timely data and analyses on important policy issues.
- Pursuant to the Social Security Act, ASPE annually calculates and publishes the Federal Medical Assistance Percentage (FMAP), enhanced Federal Medicaid Assistance Percentage (e-FMAP), and disaster-recovery FMAP for all states, the District of Columbia, and territories. The FMAP is used to determine federal funding for Medicaid/CHIP, Temporary Assistance for Needy Families (TANF) Contingency Funds, and other public programs. The FY 2022 FMAP notice was published in the Federal Register on November 30, 2020.
Noteworthy
Reports
Displaying 91 - 100 of 614. 10 per page. Page 10.
Advanced SearchASPE Data Point
Hospitalization Cost Savings Associated with COVID-19 Vaccinations Among Medicare Beneficiaries in Early 2021
ASPE Issue Brief
Transition Options, Opportunities for Integration, and Funding Considerations Following Coordinated Specialty Care Issue Brief
This brief is the third publication from the Continuity of Care Services Following Coordinated Specialty Care study. It provides a short overview of the different approaches to continuity of care for young adults who have attended CSC programs and explores avenues for integration within programs and organizations as a way to support young adults following a completion of a CSC program.
Report
The Coordinated Specialty Care Transition Study: Final Report
The Coordinated Specialty Care Transition Study: Final Report provides an overview of transition services for clients graduating from Coordinated Specialty Care (CSC). This the second publication from the Continuity of Care Services Following Coordinated Specialty Care study.
ASPE Data Point
Changes in Ownership of Hospital and Skilled Nursing Facilities: An Analysis of Newly-Released CMS Data
This report analyzes newly-released data from CMS that provides information on changes in ownership among hospitals and skilled nursing facilities (SNFs), based on information reported to CMS through the Provider Enrollment, Chain, and Ownership System (PECOS).
ASPE Issue Brief
Quality of Federal COVID-19 Data
This analysis applies the Federal Committee on Statistical Methodology's Data Quality Framework to assess the data quality of federal data for understanding and responding to the COVID-19 pandemic, focusing on five COVID-19 indicators: testing, cases, hospitalizations, deaths, and vaccinations.
Addressing Social Determinants of Health: Examples of Successful Evidence-Based Strategies and Current Federal Efforts
Long-standing health inequities and poor health outcomes remain a pressing policy challenge in the U.S. While opportunities to advance health equity through clinical care continue to be important, addressing the ways in which social determinants of health (SDOH) increase or decrease the risk of poor health outcomes is critical to improving the nation’s health and wellbeing.
Report
FY 2023 HHS Evaluation Plan
This Annual Evaluation Plan is one of several required Evidence Act products, including the 4-year Evidence-Building Plan (also referred to as the Learning Agenda), Capacity Assessment, and agency Evaluation Policy. The FY2023 Evaluation Plan priority areas are aligned with the goals of the FY 2022-2026 HHS Strategic Plan and the FY 2023- 2026 HHS Evidence-Building Plan.
Report
FY 2023-2026 HHS Capacity Assessment
Under the Foundations for Evidence-Based Policymaking Act of 2018 (Evidence Act), the Capacity Assessment requires agencies to assess the coverage, quality, methods, effectiveness, and independence of their statistics, evaluation, research, and analysis efforts.
Report
FY 2023-2026 HHS Evidence-Building Plan
The HHS Evidence Building Plan, required by the Evidence Act, is a systematic plan for identifying and addressing policy questions relevant to the programs, policies, and regulations of the agency.
Report
Scoping Review Report: Data Elements for Research on the Role of Social Determinants of Health in Coronavirus Disease 2019 Infection and Outcomes in the U.S.
The rapid emergence of the novel Coronavirus Disease 2019 (COVID-19) pandemic spurred national concerns about the social determinants of health (SDOH) as risk factors for infection and their potential to negatively impact health outcomes.